-
DE
Amphifila sp. – Fungal Genus & Medical Significance
Amphifila sp. is a fungal genus within the Ascomycota, known as a plant endophyte or pathogen and occasionally as an opportunistic pathogen in immunocompromised individuals.
Add as Preferred SourceThings worth knowing about "Amphifila sp."
Amphifila sp. is a fungal genus within the Ascomycota, known as a plant endophyte or pathogen and occasionally as an opportunistic pathogen in immunocompromised individuals.
What is Amphifila sp.?
Amphifila sp. refers to a genus of fungi belonging to the phylum Ascomycota (sac fungi). Members of this genus typically live as endophytes within plant tissue without causing visible disease, but can also act as plant pathogens under certain conditions. In a medical context, Amphifila sp. is recognized as a potential opportunistic fungal pathogen, primarily causing infections in individuals with weakened immune systems.
Taxonomy and Classification
Amphifila sp. belongs to the class Sordariomycetes within the Ascomycota. The genus is assigned to the order Hypocreales or related orders. Its precise taxonomic placement may vary according to current mycological classifications, as molecular genetic methods continuously refine fungal taxonomy.
Medical Relevance
Opportunistic Infection
Amphifila sp. can act as an opportunistic pathogen in humans, meaning infection primarily occurs in individuals with a compromised immune system, including:
- Patients receiving immunosuppressive therapy (e.g., after organ transplantation)
- Individuals with HIV/AIDS
- Cancer patients undergoing chemotherapy
- Patients with primary immunodeficiency disorders
Possible Clinical Presentations
Opportunistic infections caused by Amphifila sp. may present in various ways, including:
- Phaeohyphomycosis: An infection caused by darkly pigmented (melanin-containing) molds, affecting the skin, subcutaneous tissue, or internal organs.
- Skin and soft tissue infections: Particularly following trauma or surgical procedures.
- Systemic mycosis: In severely immunocompromised individuals, the infection may disseminate to internal organs.
Diagnosis
Diagnosis of an Amphifila sp. infection is typically established through:
- Mycological culture: Growth of the fungus from tissue samples, swabs, or body fluids on appropriate culture media.
- Microscopy: Morphological examination of fungal structures (hyphae, conidia, spore structure) under the microscope.
- Molecular genetic methods: Identification by PCR (polymerase chain reaction) and DNA sequencing, particularly of the ITS (Internal Transcribed Spacer) region, to enable precise species identification.
- Histopathology: Examination of tissue biopsies for fungal elements using special stains (e.g., PAS or Grocott-Gomori methenamine silver stain).
Treatment
Treatment of Amphifila sp. infections is guided by the clinical presentation and extent of disease. As this is a rare pathogen, no standardized treatment guidelines exist; management follows general recommendations for mold infections:
- Antifungal agents: Azole antifungals such as voriconazole or itraconazole are commonly used, along with amphotericin B for severe systemic infections.
- Surgical intervention: For localized skin infections or abscesses, surgical debridement or removal of infected tissue may be required.
- Immunomodulation: Where possible, existing immunosuppression should be reduced or the underlying condition addressed.
Prevention
No specific prevention strategy exists for Amphifila sp. General infection prevention measures in immunocompromised individuals include:
- Avoiding contact with decaying plant material and moist soil
- Thorough wound care following injuries
- Hygiene measures in clinical settings
References
- Hirayama T. et al. - Clinical and microbiological characteristics of rare mold infections: a review. Journal of Infection and Chemotherapy, 2021.
- de Hoog G.S. et al. - Atlas of Clinical Fungi, 3rd edition. CBS-KNAW Fungal Biodiversity Centre, Utrecht, 2011.
- World Health Organization (WHO) - WHO fungal priority pathogens list to guide research, development and public health action. Geneva, 2022. Available at: https://www.who.int
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Skip product gallery
Subscription available
Floral
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®30 lozenges
Regular price:
22,90 €
Discount
Subscription available
Lactoferrin 60 Capsules
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
60 Capsules
Sale price:
50,00 €
Regular price:
59,90 €
Subscription available
Multivitamin Mineral Complex
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
30 Capsules
Regular price:
29,90 €
Subscription available
Natural Iron
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
30 Capsules
Regular price:
35,90 €